title: Interleukin 2 treatment does not modify hepatitis B or C replication in human immunodeficiency virus-infected patients: results from a randomized control trial.
authors.forename: Vincent
authors.initials: V
authors.lastname: Thibault
authors.forename: Constance
authors.initials: C
authors.lastname: Delaugerre
authors.forename: Vincent
authors.initials: V
authors.lastname: Calvez
authors.forename: Dominique
authors.initials: D
authors.lastname: Costagliola
authors.forename: Roland
authors.initials: R
authors.lastname: Tubiana
authors.forename: Christine
authors.initials: C
authors.lastname: Katlama
mesh_terms: D015658:HIV Infections / Q000150:complications*; D016174:Hepacivirus / Q000502:physiology*; D006509:Hepatitis B / Q000150:complications / Q000821:virology; D006515:Hepatitis B virus / Q000502:physiology*; D006526:Hepatitis C / Q000150:complications / Q000821:virology; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D007376:Interleukin-2